IBD Innovate: Product Development for Crohn’s and Colitis
Cambridge, United States, 09 - 10 Apr 2024
Dr. Huw Davies, our VP of Business Development, Research Products and Services, will be presenting “Developing a non-invasive breath test for IBD using volatile probes” at the IBD INNOVATE: Product Development for Crohn’s & Colitis event.
The meeting aims to build awareness and connections across the IBD product development ecosystem, with the aim to exchange knowledge and evaluate potential fit for new product development. This event will showcase innovative product development programs in IBD and offer extensive partnering and networking opportunities.
Dr Huw Davies has over 30 years experience working with novel technologies that enable the diagnosis and treatment of major human diseases. In his current role, Huw leads a global commercial team responsible for growing Owlstone Medical’s Breath Biopsy® collaborations and service business with leading pharmaceutical companies and academic partners to identify and deploy novel non-invasive breath biomarkers for precision medicine and disease diagnosis.